Charles Schwab’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-71,774
| Closed | -$9.45M | – | 3547 |
|
|
2020
Q4 | $9.45M | Sell |
71,774
-21,553
| -23% | -$2.84M | ﹤0.01% | 1899 |
|
|
2020
Q3 | $4.72M | Buy |
93,327
+21,901
| +31% | +$1.11M | ﹤0.01% | 2088 |
|
|
2020
Q2 | $3.41M | Buy |
71,426
+24,200
| +51% | +$1.15M | ﹤0.01% | 2205 |
|
|
2020
Q1 | $2.31M | Buy |
47,226
+747
| +2% | +$36.6K | ﹤0.01% | 2217 |
|
|
2019
Q4 | $2.67M | Buy |
46,479
+3,180
| +7% | +$183K | ﹤0.01% | 2326 |
|
|
2019
Q3 | $1.56M | Sell |
43,299
-3,944
| -8% | -$142K | ﹤0.01% | 2463 |
|
|
2019
Q2 | $1.47M | Sell |
47,243
-9,361
| -17% | -$291K | ﹤0.01% | 2463 |
|
|
2019
Q1 | $1.33M | Buy |
56,604
+22,049
| +64% | +$517K | ﹤0.01% | 2473 |
|
|
2018
Q4 | $476K | Buy |
34,555
+3,021
| +10% | +$41.6K | ﹤0.01% | 2788 |
|
|
2018
Q3 | $315K | Buy |
+31,534
| New | +$315K | ﹤0.01% | 2992 |
|